VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC 深 沪
等待开盘 08-12 09:30:00 美东时间
64.7432
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 64.7432
- 总市值 7.45亿
- 52周最高 66.1391
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 56.5095
- 委 比 0.00%
- 总股本 1149.93万
- 历史最高 67.1649
- 量 比 0
- 振 幅 0.00%
- 历史最低 15.0841
- 每 手 1
- 风险率 1.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Former Surgeon General Slams RFK Jr. Over mRNA Cuts, Says US 'Conceding To China,' 2 Million Lives At Risk
Adams warns cutting funding for mRNA vaccine research will cost lives, derail medical progress, and give China an advantage.
08-11 17:11
美国卫生部撤回mRNA疫苗开发拨款 众多疫苗大厂“中枪”
作为长期的“疫苗怀疑论”鼓吹者，肯尼迪此举并不令人意外。肯尼迪在社交媒体上发布视频称，美国生物医学高级研究与发展管理局（BARDA）已经取消了22份总额不到5亿...
08-06 13:40
BioNTech posts Q2 beat as revenue more than doubles
BioNTech (NASDAQ:BNTX) ADRs added ~2% in the premarket on Monday after the German vaccine maker exceeded Street forecasts with its Q2 2025 financials, thanks mainly to an over two-fold rise in its rev...
08-04 19:38
BioNTech GAAP EPS of -€1.60, revenue of €260.8M
BioNTech press release (NASDAQ:BNTX): Q2 GAAP EPS of -€1.60. Revenue of €260.8M (+102.6% Y/Y). Revenues for the 2025 financial year €1,700 million - €2,200 million More on BioNTech BioNTech: More Unce...
08-04 18:47
'Trump Administration Blocks Funding for CDC Health Programs'- WSJ
https://www.wsj.com/politics/policy/trump-cdc-funding-freeze-79e7090f
08-02 04:30
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors or individual stocks. President Trump sent letters to 17 major pharmaceutical makers advising them ...
08-02 01:02
Experts helping vaccine advisors are reportedly ousted at CDC
The CDC has informed public health experts and physician organizations, whose views are considered in shaping the U.S. vaccine policy, that their services are no longer required for a key vaccine advi...
08-01 23:07
Moderna to lay off 10% of staff this year
Moderna (NASDAQ:MRNA) CEO Stephane Bancel announced on Thursday that the company plans to cut nearly 10% of its global workforce by the end of 2025, marking the COVID-19 vaccine maker’s latest restruc...
07-31 20:39
GSK gives Q2 results, revises outlook
GSK press release (NYSE:GSK): Q2 Non-GAAP EPS of 46.50p Revenue of £7.99B (+1.1% Y/Y) Specialty Medicines sales £3.3 billion (+15%); Respiratory, Immunology & Inflammation £1.0 billion (+10%); Oncolog...
07-30 17:04
